Farrell F - Search Results

1

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous dose administration in cynomolgus monkeys.

Ramakrishnan R, Cheung WK, Farrell F, Joffee L, Jusko WJ. Ramakrishnan R, et al. Among authors: farrell f. J Pharmacol Exp Ther. 2003 Jul;306(1):324-31. doi: 10.1124/jpet.102.047191. Epub 2003 Apr 3. J Pharmacol Exp Ther. 2003. PMID: 12676891

2

The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.

Xenocostas A, Cheung WK, Farrell F, Zakszewski C, Kelley M, Lutynski A, Crump M, Lipton JH, Kiss TL, Lau CY, Messner HA. Xenocostas A, et al. Among authors: farrell f. Eur J Clin Pharmacol. 2005 May;61(3):189-95. doi: 10.1007/s00228-005-0896-7. Epub 2005 Mar 18. Eur J Clin Pharmacol. 2005. PMID: 15776276 Clinical Trial.

3

Erytropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin.

Juul SE, McPherson RJ, Farrell FX, Jolliffe L, Ness DJ, Gleason CA. Juul SE, et al. Biol Neonate. 2004;85(2):138-44. doi: 10.1159/000074970. Epub 2003 Nov 24. Biol Neonate. 2004. PMID: 14639039

4

Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models.

LaMontagne KR, Butler J, Marshall DJ, Tullai J, Gechtman Z, Hall C, Meshaw A, Farrell FX. LaMontagne KR, et al. Mol Cancer Ther. 2006 Feb;5(2):347-55. doi: 10.1158/1535-7163.MCT-05-0203. Mol Cancer Ther. 2006. PMID: 16505108

5

The effect of cumulative dosing on the analgesic potency of morphine in mice.

Duttaroy A, Kirtman R, Farrell F, Phillips M, Philippe J, Monderson T, Yoburn BC. Duttaroy A, et al. Among authors: farrell f. Pharmacol Biochem Behav. 1997 Sep;58(1):67-71. doi: 10.1016/s0091-3057(96)00463-7. Pharmacol Biochem Behav. 1997. PMID: 9264072

6

The erythropoietin receptor and its expression in tumor cells and other tissues.

Farrell F, Lee A. Farrell F, et al. Oncologist. 2004;9 Suppl 5:18-30. doi: 10.1634/theoncologist.9-90005-18. Oncologist. 2004. PMID: 15591419 Free article. Review.

7

Erythropoietin induces changes in gene expression in PC-12 cells.

Renzi MJ, Farrell FX, Bittner A, Galindo JE, Morton M, Trinh H, Jolliffe LK. Renzi MJ, et al. Brain Res Mol Brain Res. 2002 Jul 15;104(1):86-95. doi: 10.1016/s0169-328x(02)00323-6. Brain Res Mol Brain Res. 2002. PMID: 12117554

8

Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity.

Johnson DL, Farrell FX, Barbone FP, McMahon FJ, Tullai J, Kroon D, Freedy J, Zivin RA, Mulcahy LS, Jolliffe LK. Johnson DL, et al. Among authors: farrell fx. Chem Biol. 1997 Dec;4(12):939-50. doi: 10.1016/s1074-5521(97)90302-1. Chem Biol. 1997. PMID: 9427659

9

Synthesis and erythropoietin receptor binding affinities of N,N-disubstituted amino acids.

Connolly PJ, Wetter SK, Murray WV, Johnson DL, McMahon FJ, Farrell FX, Tullai J, Jolliffe LK. Connolly PJ, et al. Among authors: farrell fx. Bioorg Med Chem Lett. 2000 Sep 4;10(17):1995-9. doi: 10.1016/s0960-894x(00)00399-1. Bioorg Med Chem Lett. 2000. PMID: 10987435

10

Small peptides as potent mimetics of the protein hormone erythropoietin.

Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ. Wrighton NC, et al. Among authors: farrell fx. Science. 1996 Jul 26;273(5274):458-64. doi: 10.1126/science.273.5274.458. Science. 1996. PMID: 8662529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page